AMT — Allegra Medical Technologies Income Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual income statement for Allegra Medical Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4 | 5.02 | 4.5 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 2.43 | 2.9 | 2.63 | 0.005 | -0.014 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4.83 | 6.17 | 5.07 | 1.88 | 1.79 |
| Operating Profit | -0.836 | -1.16 | -0.566 | -1.88 | -1.79 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.836 | -1.17 | -0.579 | -2.02 | -2.09 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.836 | -1.17 | -0.579 | -2.02 | -2.09 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.836 | -1.17 | -0.579 | -2.54 | -3.65 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.836 | -1.17 | -0.579 | -2.54 | -3.65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.008 | -0.012 | -0.006 | -0.019 | -0.02 |